| MeSH term | MeSH ID | Detail |
|---|---|---|
| Parkinson Disease, Secondary | D010302 | 17 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Obesity | D009765 | 29 associated lipids |
| Neuroblastoma | D009447 | 66 associated lipids |
| Neuralgia | D009437 | 28 associated lipids |
| Nervous System Diseases | D009422 | 37 associated lipids |
| Nerve Degeneration | D009410 | 53 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Neoplasms | D009369 | 13 associated lipids |
| Neoplasm Invasiveness | D009361 | 23 associated lipids |
Anandamide
Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
Cross Reference
Introduction
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Anandamide?
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Anandamide
PubChem Associated disorders and diseases
What pathways are associated with Anandamide
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Anandamide?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Anandamide?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Anandamide?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Anandamide?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Anandamide?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Anandamide
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Moloney GP et al. | Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor. | 2008 | Eur J Med Chem | pmid:17582659 |
| Panagis G et al. | Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. | 2008 | Curr Drug Abuse Rev | pmid:19630731 |
| Snider NT et al. | The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6. | 2008 | J. Pharmacol. Exp. Ther. | pmid:18698000 |
| Xiong W et al. | Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. | 2008 | Mol. Pharmacol. | pmid:17993512 |
| Hill MN et al. | Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. | 2008 | Hippocampus | pmid:18058925 |
| Moreira FA et al. | Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. | 2008 | Neuropharmacology | pmid:17709120 |
| Gorzalka BB et al. | Endocannabinoid modulation of male rat sexual behavior. | 2008 | Psychopharmacology (Berl.) | pmid:17694389 |
| Rueda-Orozco PE et al. | A potential function of endocannabinoids in the selection of a navigation strategy by rats. | 2008 | Psychopharmacology (Berl.) | pmid:17805517 |
| Engeli S et al. | Peripheral endocannabinoid system activity in patients treated with sibutramine. | 2008 | Obesity (Silver Spring) | pmid:18356837 |
| Wise LE et al. | Evaluation of fatty acid amides in the carrageenan-induced paw edema model. | 2008 | Neuropharmacology | pmid:17675189 |
| Ahn K et al. | Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. | 2008 | Chem. Rev. | pmid:18429637 |
| Rubio M et al. | CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. | 2008 | Neuropharmacology | pmid:18371990 |
| Evans RM et al. | Modulation of sensory neuron potassium conductances by anandamide indicates roles for metabolites. | 2008 | Br. J. Pharmacol. | pmid:18376419 |
| Di Marzo V and Maccarrone M | FAAH and anandamide: is 2-AG really the odd one out? | 2008 | Trends Pharmacol. Sci. | pmid:18394720 |
| Kaufmann I et al. | Anandamide and neutrophil function in patients with fibromyalgia. | 2008 | Psychoneuroendocrinology | pmid:18395993 |
| Hegde VL et al. | Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. | 2008 | Mol. Pharmacol. | pmid:18388242 |
| Solinas M et al. | The endocannabinoid system in brain reward processes. | 2008 | Br. J. Pharmacol. | pmid:18414385 |
| Richardson D et al. | Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. | 2008 | Arthritis Res. Ther. | pmid:18416822 |
| Farrell EK and Merkler DJ | Biosynthesis, degradation and pharmacological importance of the fatty acid amides. | 2008 | Drug Discov. Today | pmid:18598910 |
| Terry G et al. | Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents. | 2008 | Neuroimage | pmid:18456516 |
| Yang Z et al. | Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. | 2008 | Biochem. Pharmacol. | pmid:18755158 |
| Yao F et al. | Development of novel tail-modified anandamide analogs. | 2008 | Bioorg. Med. Chem. Lett. | pmid:18723350 |
| Kase Y et al. | Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock. | 2008 | Ther Apher Dial | pmid:18937720 |
| Wang J et al. | Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells. | 2008 | J. Biochem. | pmid:18806270 |
| Murillo-RodrÃguez E et al. | The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. | 2008 | Neuroscience | pmid:18822353 |
| Woo DH et al. | Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG). | 2008 | Mol Pain | pmid:18826653 |
| DeMorrow S et al. | The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. | 2008 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:18832445 |
| Dembiński A et al. | Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves. | 2008 | Eur. J. Pharmacol. | pmid:18593574 |
| Stark K et al. | Expression and purification of orphan cytochrome P450 4X1 and oxidation of anandamide. | 2008 | FEBS J. | pmid:18549450 |
| Kamei J et al. | [Sensitization of cough sensitivity through activation of C-and/or Adelta fibers]. | 2008 | Nippon Yakurigaku Zasshi | pmid:18552444 |
| Thors L et al. | Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids. | 2008 | Br. J. Pharmacol. | pmid:18552875 |
| Ellgren M et al. | Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. | 2008 | Eur Neuropsychopharmacol | pmid:18674887 |
| Fowler CJ and Ghafouri N | Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? | 2008 | Pharmacol. Res. | pmid:18675915 |
| Hashiguchi T et al. | Systematic evaluation of nitric oxide, tetrahydrobiopterin, and anandamide levels in a porcine model of endotoxemia. | 2008 | J Anesth | pmid:18685926 |
| Lisboa SF et al. | Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. | 2008 | Eur. J. Pharmacol. | pmid:18691568 |
| Currie S et al. | IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. | 2008 | J. Mol. Cell. Cardiol. | pmid:18692061 |
| Turco MY et al. | High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation. | 2008 | Hum. Reprod. | pmid:18614613 |
| Maccarrone M | Anandamide as a marker of human disease. | 2008 | JAMA | pmid:18632539 |
| Hill MN et al. | Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. | 2008 | J. Neurochem. | pmid:18643796 |
| Haller VL et al. | Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. | 2008 | Eur. J. Pharmacol. | pmid:18762181 |
| da Veiga MA et al. | Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion. | 2008 | J. Endocrinol. | pmid:18755884 |
| DeMorrow S et al. | Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. | 2008 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:18096608 |
| Scherma M et al. | The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. | 2008 | Neuropharmacology | pmid:17904589 |
| Bjursell M et al. | Acutely reduced locomotor activity is a major contributor to Western diet-induced obesity in mice. | 2008 | Am. J. Physiol. Endocrinol. Metab. | pmid:18029443 |
| Williams MA et al. | The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor. | 2008 | J. Physiol. (Lond.) | pmid:18063665 |
| Rubino T et al. | Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. | 2008 | Cereb. Cortex | pmid:17921459 |
| Justinova Z et al. | Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. | 2008 | Biol. Psychiatry | pmid:18814866 |
| Muccioli GG and Stella N | An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. | 2008 | Anal. Biochem. | pmid:17981259 |
| Thiemann G et al. | The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization. | 2008 | Behav. Brain Res. | pmid:17988751 |
| Correa F et al. | Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2). | 2008 | Biochem. J. | pmid:17961121 |